C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2011
10/11/2011	US8034351 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/11/2011	US8034348 Prevention and treatment of amyloidogenic disease
10/11/2011	US8034347 Method for inhibiting apoptosis through the p75 neurotrophin receptor
10/11/2011	US8034343 Methods of treating inflammatory disorders of the lungs
10/11/2011	US8034342 for treating degenerative cartilaginous disorders and other inflammatory diseases; interleukin-17 receptor protein
10/11/2011	US8034341 Methods of inhibiting tumor growth using blocking antibodies to IL-23R
10/11/2011	US8034339 administering an antibody that specifically binds to the amyloid deposit or a component thereof; can be a human, humanized, chimeric or nonhuman antibody and can be monoclonal or polyclonal; also a novel monoclonal antibody which specifically binds to an epitope within residues 13-28 of A beta
10/11/2011	US8034336 Antibodies against a peptide epitope of apoliprotein B
10/11/2011	US8034332 Interleukin-secreting natural killer cell lines and methods of use
10/11/2011	US8034330 Modified organs and cells for xenotransplantation
10/11/2011	US8034314 Photoreactive compound specifically binding to calcium binding proteins
10/11/2011	CA2563344C Cytokinin oxidase sequences and methods of use
10/11/2011	CA2504938C Compositions and methods for treating or preventing pneumococcal infection
10/11/2011	CA2468258C Peptide agonists of prostate-specific antigen, and uses therefor
10/11/2011	CA2465327C Nonhuman model animal of th2-mediated hyperimmune response
10/11/2011	CA2447538C Cellular signal-responsive gene transcriptional regulation system
10/11/2011	CA2442993C Nucleic acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/11/2011	CA2438094C Increased recovery of active proteins
10/11/2011	CA2427665C Method for the production of a heterologous protein by a fungus
10/11/2011	CA2416475C Medicinal uses of mu-opioid receptor agonists
10/11/2011	CA2394862C Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder
10/11/2011	CA2341356C Poxvirus with targeted infection specificity
10/11/2011	CA2248937C Peptide-based immunotherapeutic agent for treating allergic diseases
10/11/2011	CA2157932C Production of human papillomavirus capsid protein and virus-like particles
10/06/2011	WO2011123785A2 Frizzled-binding agents and uses thereof
10/06/2011	WO2011123683A2 Protease activated cytokines
10/06/2011	WO2011123570A2 Methods for g-csf production in a pseudomonas host cell
10/06/2011	WO2011123505A1 Processes of producing a fermentation product
10/06/2011	WO2011123495A1 Influenza virus vaccines and uses thereof
10/06/2011	WO2011123396A1 Compositions and methods for the removal of biofilms
10/06/2011	WO2011123179A2 Alkylated sp-c peptoid compounds and related surfactant compositions
10/06/2011	WO2011123041A1 Fertilization prediction and promotion
10/06/2011	WO2011122950A1 Monomeric duplex aav vectors
10/06/2011	WO2011122761A2 Gsdl2 protein having a life-extension function for plants and a stress resistance function for plants, gene thereof, and use thereof
10/06/2011	WO2011122740A1 Environmental stress-inducible 557 promoter isolated from rice and uses thereof
10/06/2011	WO2011122127A1 Peptide having osteoblast proliferation promotion activity and use thereof
10/06/2011	WO2011121289A2 Compounds and their use
10/06/2011	WO2011121257A1 Tools for the identification of lingo-1, lingo-2, lingo-3 and lingo-4, ligands, and uses thereof
10/06/2011	WO2011121123A1 Factor xii inhibitors for treating interstitial lung disease
10/06/2011	WO2011121031A1 Process for the purification of a growth factor protein
10/06/2011	WO2011120994A1 Pharmaceutical compositions comprising a polypeptide comprising at least one cxxc motif and heterologous antigens and uses thereof
10/06/2011	WO2011120993A1 Polypeptides having transgalactosylating activity
10/06/2011	WO2011120885A1 Hcv ns5a replicon shuttle vectors
10/06/2011	WO2011120859A1 Fusion protein and its uses
10/06/2011	WO2011120549A1 Method of enhancing the seed yield and promoting the growth of plants
10/06/2011	WO2011120474A1 Method for inhibiting hiv replication in mammal and human cells
10/06/2011	WO2011120135A1 Antibodies with enhanced or suppressed effector function
10/06/2011	WO2011120134A1 Antibodies with enhanced or suppressed effector function
10/06/2011	WO2011077309A3 Vaccine compositions
10/06/2011	WO2011073215A3 Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
10/06/2011	WO2011054359A3 Method for early detection of cancer using o - glycosylated mucin peptides or corresponding monoclonal antibodies
10/06/2011	WO2011029881A3 A method for binding a recombinant polypeptide to a carrier
10/06/2011	WO2010089554A8 Grass peptides for vaccine
10/06/2011	WO2009100489A8 Crystal structure of pfa-mi and the pfa-mi co4 complex
10/06/2011	US20110247101 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
10/06/2011	US20110247097 Plants having modified growth characteristics and a method for making the same
10/06/2011	US20110247095 Method of expression of foreign gene in plant induced by chemical substance
10/06/2011	US20110247087 Regulation of endogenous gene expression in cells using zinc finger proteins
10/06/2011	US20110245772 Focal calcium channel modulation
10/06/2011	US20110245474 Methods for g-csf production in a pseudomonas host cell
10/06/2011	US20110245471 NUCLEAR FACTOR kappaB INDUCING FACTOR
10/06/2011	US20110245465 Methods for Detection of Methyl-CpG Dinucleotides
10/06/2011	US20110245464 Highly thermostable fluorescent proteins
10/06/2011	US20110245463 Apparatus and method for structure-based prediction of amino acid sequences
10/06/2011	US20110245330 P185neu-encoding dna and therapeutical uses thereof
10/06/2011	US20110245326 Post-Transcriptional Regulation Of RNA-Related Processes Using Encoded Protein-Binding RNA Aptamers
10/06/2011	US20110245186 Recombinant e-selectin made in insect cells
10/06/2011	US20110245185 APO-2 ligand/trail formulations
10/06/2011	US20110245176 Novel peptides that bind to the erythropoietin receptor
10/06/2011	US20110245173 Long-Acting GLP-1 Derivatives, and Methods of Treating Cardiac Dysfunction
10/06/2011	US20110245168 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
10/06/2011	US20110245166 Sugar chain added glp-1 peptide
10/06/2011	US20110245165 Peptide agonists of glp-1 activity
10/06/2011	US20110245164 Yl-based insulin-like growth factors exhibiting high activity at the insulin receptor
10/06/2011	US20110245163 Stabilised Insulin Compositions
10/06/2011	US20110245153 Neutralizing Agents for Bacterial Toxins
10/06/2011	US20110245152 Antibiotic antimicrobial agents and methods of their use
10/06/2011	US20110245151 Bacteriocins and Novel Bacterial Strains
10/06/2011	US20110245147 Activation of Peptide Prodrugs by HK2
10/06/2011	US20110245146 Non-Viral Delivery of Compounds to Mitochondria
10/06/2011	US20110245145 Methods and reagents for the diagnosis, prevention and treatment of insulin resistance
10/06/2011	US20110245096 Compositions and methods for the treatment of immune related diseases
10/06/2011	US20110245090 Compositions and methods for the treatment of immune related diseases
10/06/2011	US20110244576 Herpes Simplex Virus Complex
10/06/2011	US20110244574 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
10/06/2011	US20110244564 Cystine knot molecules
10/06/2011	US20110244563 Assays that use the t1r1 receptor polypeptides to screen for t1r1-associated taste modulators
10/06/2011	US20110244545 Polymeric carriers for immunohistochemistry and in situ hybridization
10/06/2011	US20110244544 Polymeric carriers for immunohistochemistry and in situ hybridization
10/06/2011	US20110244514 Mammalian Sweet Taste Receptors
10/06/2011	US20110244513 Isolated mammalian membrane protein genes; related reagents
10/06/2011	US20110244507 USE OF NEUREGULIN-ß AS AN INDICATOR AND/OR TARGET
10/06/2011	US20110244500 Gel electrophoresis method useful for resolution and characterization of nerve tissue ultra high molecular weight protein aggregates
10/06/2011	US20110244491 Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides
10/06/2011	US20110244486 Methods and compositions for the diagnosis and treatment of diabetes
10/06/2011	US20110244484 Method of diagnosing alzheimer's disease using giant magnetoresistance sensor and magnetic bead-polyprotein complex for diagnosing alzheimer's disease
10/06/2011	US20110244481 Coelenterazine analogues and coelenteramide analogues
10/06/2011	US20110244053 Use a goat serum for veterinary treatment
10/06/2011	US20110243995 Method for Rational Mutagenesis of Alpha/Beta T-Cell Receptors and Correspondingly Mutated MDM2-Protein Specific Alpha/Beta T-Cell Receptors
10/06/2011	US20110243981 Therapeutic myelin sheath derived antagonist peptide conjugates

1 ... 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 ... 2916